Social Media Ideas for Covid-19 Vaccines

Leveraging Data Science for COVID-19 Vaccine Administration | Simplilearn

Globally, over 30 million doses of the COVID-19 vaccination have been dispensed throughout 43 countries. In the U.S., over nine million people have had at least one COVID-19 vaccin...

mRNA vaccines clear sweeping global review of safety and effectiveness

A comprehensive global review has found that mRNA vaccines aren't just highly effective at fighting infectious diseases – they are also very safe.Continue ReadingCategory:

The Vaccine Distribution Supply Chain!

As the Covid-19 Coronavirus has wreaked havoc with everyone’s lives all over the world there is great hope for a vaccine to allow us to get back to normal. While all of the social...

App helps remove vaccine barriers for families

Vaccines help the immune system to recognize and fight many types of diseases, from viral illnesses like COVID-19 to bacterial infections like tetanus. In 2024, the United States C...

Have COVID-19 vaccines contributed to as many as 3.9 million deaths? 

Surprising benefit of Covid vaccine found in new study

The study found that the jab was linked to a lower risk of Covid-19-related major adverse cardiovascular events

COVID-19 Vaccine Distribution: Addressing Data Challenges | Simplilearn

Distributing the COVID-19 vaccine is a logistical puzzle that teeters on a delicate structure of chemists, data scientists, freight drivers, healthcare professionals, distributors,...

The Lancet: Τα εμβόλια mRNA κατά του Covid είναι ασφαλή και εξαιρετικά αποτελεσματικά

Σύμφωνα με νέα μεγάλη ανασκόπηση στο «The Lancet», τα εγκεκριμένα mRNA εμβόλια κατά της Covid-19 είναι ασφαλή και αποτελεσματικά

FACT CHECK: Claim that COVID-19 vaccine recipients will only live until 2030 is false

There is no evidence that COVID-19 vaccines significantly shorten life expectancy; vaccines undergo a rigorous process and clinical trials before being rolled out for public use to...

Billions of doses of mRNA vaccines confirm they are safe and effective

A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects substantially outweighed by benefits.

A vaccine designed using AI has just been tested in humans

Neil Mabbott, University of Edinburgh/ The ConversationContinue ReadingCategory: Infectious Diseases, Illnesses and conditions,

Cancer vaccines based on mRNA advance, despite US cuts

CHICAGO:  Treatments based on the same mRNA technology that delivered COVID-19 vaccines ​to market in record time are showing lasting benefit against the deadly ​skin cancer melano...

<![CDATA[FDA Advisory Panel to Vote on Composition of Covid-19 Vaccines for 2026-2027 ]]>

BNT162b2 Early Vaccine Effective Against COVID-19 Visits

In a pivotal advancement in the ongoing battle against the COVID-19 pandemic, a recent study published in Nature Communications has illuminated the early effectiveness of the BNT16...

Six Years After the First COVID-19 mRNA Vaccines, Billions of Doses Clarify Their Protection and Rare Risks

Learn how mRNA vaccines work, why serious risks remain rare, and how the technology could be used beyond COVID-19.

Three Ebola vaccines in development amid growing outbreak fears

IAVI, Moderna and the University of Oxford are all working on new vaccines.

OB-GYN group breaks with CDC and issues own vaccine recommendations

The biggest difference involves the COVID-19 vaccine

A Better Flu Vaccine

by Gertrud U. Rey On June 18, 2026, the top advisory committee for the Food and Drug Administration (FDA) unanimously recommended Moderna’s new mRNA influenza vaccine, mRNA‑1010 (m...

World's first AI-designed vaccine developed by UK scientists enters human trials

A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and B...

Older and vulnerable residents urged to book spring Covid jab

The NHS continues to encourage those who remain eligible to book their Covid jab before the scheme ends on June 30.

'World-first' vaccine designed by artificial intelligence

Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.

Your menstrual cycle may affect how well vaccines work

Women who were vaccinated against covid-19 in the luteal phase of their menstrual cycle reported having a breakthrough infection sooner than those vaccinated during their follicula...

The worlds first AI-designed vaccine, explained

Researchers at the University of Cambridge have developed a vaccine using artificial intelligence. How does the AI-designed vaccine work?

The ‘World-first’ vaccine designed by artificial intelligence has been achieved

According to a report from the BBC, researchers at the University of Cambridge have achieved a significant breakthrough by using artificial intelligence to design a novel vaccine c...